肝细胞癌的经皮治疗

V. Sitruk (ancien Chef de clinique-assistant) , O. Seror (Praticien hospitalier) , J.-C. Trinchet (Professeur des Universités Praticien hospitalier)
{"title":"肝细胞癌的经皮治疗","authors":"V. Sitruk (ancien Chef de clinique-assistant) ,&nbsp;O. Seror (Praticien hospitalier) ,&nbsp;J.-C. Trinchet (Professeur des Universités Praticien hospitalier)","doi":"10.1016/j.emchep.2004.07.002","DOIUrl":null,"url":null,"abstract":"<div><p>Despite advances in imaging techniques and surveillance program, most hepatocellular carcinoma patients are still diagnosed at advanced stages and cannot benefit from surgical curative treatment. Percutaneous destruction of tumour by chemical substances or thermal energy sources is a good alternative to surgery. Percutaneous ethanol injection, the earliest developed method, has been widely reported and has proven its efficacy achieving a complete response in 80-100 % of hepatocellular carcinoma less than 3 cm in diameter. It is simple, safe and cheap and is until now the gold standard in percutaneous treatments. Over the past 10 years, methods using thermotherapy (radiofrequency, microwaves, laser) have been developed. Radiofrequency is the most assessed method and it achieves at least the same response as percutaneous ethanol injection but with a complication rate which could be higher. Microwave and laser are promising technologies, but only few clinical data are available. Randomized controlled trials are needed in order to assess treatment response, long-term survival, safety and cost-efficacy of the new techniques.</p></div>","PeriodicalId":100427,"journal":{"name":"EMC - Hépatologie","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2004-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.emchep.2004.07.002","citationCount":"8","resultStr":"{\"title\":\"Traitement percutané du carcinome hépatocellulaire\",\"authors\":\"V. Sitruk (ancien Chef de clinique-assistant) ,&nbsp;O. Seror (Praticien hospitalier) ,&nbsp;J.-C. Trinchet (Professeur des Universités Praticien hospitalier)\",\"doi\":\"10.1016/j.emchep.2004.07.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Despite advances in imaging techniques and surveillance program, most hepatocellular carcinoma patients are still diagnosed at advanced stages and cannot benefit from surgical curative treatment. Percutaneous destruction of tumour by chemical substances or thermal energy sources is a good alternative to surgery. Percutaneous ethanol injection, the earliest developed method, has been widely reported and has proven its efficacy achieving a complete response in 80-100 % of hepatocellular carcinoma less than 3 cm in diameter. It is simple, safe and cheap and is until now the gold standard in percutaneous treatments. Over the past 10 years, methods using thermotherapy (radiofrequency, microwaves, laser) have been developed. Radiofrequency is the most assessed method and it achieves at least the same response as percutaneous ethanol injection but with a complication rate which could be higher. Microwave and laser are promising technologies, but only few clinical data are available. Randomized controlled trials are needed in order to assess treatment response, long-term survival, safety and cost-efficacy of the new techniques.</p></div>\",\"PeriodicalId\":100427,\"journal\":{\"name\":\"EMC - Hépatologie\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2004-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.emchep.2004.07.002\",\"citationCount\":\"8\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EMC - Hépatologie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1638622104000132\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EMC - Hépatologie","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1638622104000132","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8

摘要

尽管成像技术和监测计划取得了进步,但大多数肝细胞癌患者仍处于晚期,无法从手术治疗中获益。通过化学物质或热能来源经皮破坏肿瘤是手术的一个很好的替代方案。经皮乙醇注射是最早开发的方法,已被广泛报道,并已证明其对直径小于3cm的肝细胞癌的疗效达到80-100%。它简单、安全、便宜,是目前经皮治疗的黄金标准。在过去的10年里,已经开发出了使用热疗(射频、微波、激光)的方法。射频是评估最多的方法,它至少达到了与经皮乙醇注射相同的反应,但并发症发生率可能更高。微波和激光是很有前途的技术,但临床数据很少。需要进行随机对照试验,以评估新技术的治疗效果、长期生存率、安全性和成本效益。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Traitement percutané du carcinome hépatocellulaire

Despite advances in imaging techniques and surveillance program, most hepatocellular carcinoma patients are still diagnosed at advanced stages and cannot benefit from surgical curative treatment. Percutaneous destruction of tumour by chemical substances or thermal energy sources is a good alternative to surgery. Percutaneous ethanol injection, the earliest developed method, has been widely reported and has proven its efficacy achieving a complete response in 80-100 % of hepatocellular carcinoma less than 3 cm in diameter. It is simple, safe and cheap and is until now the gold standard in percutaneous treatments. Over the past 10 years, methods using thermotherapy (radiofrequency, microwaves, laser) have been developed. Radiofrequency is the most assessed method and it achieves at least the same response as percutaneous ethanol injection but with a complication rate which could be higher. Microwave and laser are promising technologies, but only few clinical data are available. Randomized controlled trials are needed in order to assess treatment response, long-term survival, safety and cost-efficacy of the new techniques.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Anomalies congénitales du pancréas Hépatopathies toxiques médicamenteuses et non médicamenteuses : généralités Autoanticorps en hépatologie Épidémiologie, histoire naturelle et traitements de l'infection virale delta Conduite à tenir devant une élévation de la gamma-glutamyl transférase
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1